In ccRCC, the PI3K–Akt signaling pathway is constitutively activated and shows critical role in cancer progression through regulating various targets, such as bromodomain-containing protein 4 (BRD4) [27] and VHL–HIF pathway [28]. The gene discussed is BRD4; the disease is nonpapillary renal cell carcinoma.